The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer

Molecular Cancer Research

Volumn 6, Issue 4, 2008, Pages 585-591

  Karpinski, Pawel ^a   Ramsey, David ^b   Grzebieniak, Zygmunt ^a   Sasiadek, Maria Malgorzata ^a   Blin, Nikolaus ^c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF LIMERICK   (Ireland)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BRAF V600E GENE; CHROMOSOME 2Q; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE; GENE LOCUS; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; METHYLATION; MLH1 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANK SUM TEST;

AGED; CHROMOSOMES, HUMAN, PAIR 2; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE SILENCING; GENES, NEOPLASM; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR MARKERS, BIOLOGICAL;

EID: 42049116316     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-2158     Document Type: Article

References (32)

1. Ting AH, McGarvey KM, Baylin SB. The cancer epigenome - components and functional correlates. Genes Dev 2006;20:3215-31.
2. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-16.
3. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-86.
4. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93.
5. Ogino S, Cantor M, Kawasaki T, et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut 2006;55:1000-6.
6. Castellvi-Bel S, Castells A. CpG island methylator phenotype: the third way of colorectal carcinogenesis. Gastroenterology 2007;132:1184-5.
7. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
8. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-9.
9. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006;38:540-9.
10. Hitchins MP, Lin VA, Buckle A, et al. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. Cancer Res 2007;67:9107-16.
11. Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 2002;122:1376-87.
12. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
13. Costello JF, Plass C. Methylation matters. J Med Genet 2001;38:285-303.
14. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21.
15. Schuebel KE, Chen W, Cope L, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007;3:1709-23.
16. Issa JP, Shen L, Toyota M. CIMP, at last. Gastroenterology 2005;129:1121-12.
17. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M. Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 2003;4:121-31.
18. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
19. Laird PW. Cancer epigenetics. Hum Mol Genet 2005;14:R65-76.
20. Chi V. Dang. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999;19:1-11.
21. Sanchez P, Clement V, Altaba AR. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. Cancer Res 2005;65:2990-2.
22. Regl R, Neill GW, Eichberger T, et al. Human GLI2 and GLI1 are part of a positive feedback mechanism in basal cell carcinoma. Oncogene 2002;21:5529-39.
23. Sterling JA, Oyajobi BO, Grubbs B, et al. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Res 2006;66:7548-53.
24. Pereira AL, Pereira AJ, Maia ARR, et al. Mammalian CLASP1 and CLASP2 cooperate to ensure mitotic fidelity by regulating spindle and kinetochore function. Mol Biol Cell 2006;17:4526-42.
25. Kasai M, Matsuzaki T, Katayanagi K, et al. The translin ring specifically recognizes DNA ends at recombination hot spots in the human genome. J Biol Chem 1997;272:11402-7.
26. Bachar-Dahan L, Goltzmann J, Yaniv A, Gazit A. Engrailed-1 negatively regulates β-catenin transcriptional activity by destabilizing β-catenin via a glycogen synthase kinase-3β-independent pathway. Mol Biol Cell 2006;17:2572-80.
27. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 2005;19:877-90.
28. Stransky N, Vallot C, Reyal F, et al. Regional copy number-independent deregulation of transcription in cancer. Nat Genet 2006;38:1386-96.
29. Clark JS. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet 2007;16:R88-95.
30. Sapio MR, Posca D, Troncone G, et al. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 2006;154:341-8.
31. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
32. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 2002;160:529-36.